P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY INCLUDING CORRELATION WITH STEROID-RECEPTOR STATUS, PROLIFERATION INDEXES, COLLAGEN TYPE-IV, LAMININ, C-ERBB-2 ONCOPROTEIN AND CATHEPSIN-D
E. Ioachim et al., P53 PROTEIN EXPRESSION IN HUMAN BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY INCLUDING CORRELATION WITH STEROID-RECEPTOR STATUS, PROLIFERATION INDEXES, COLLAGEN TYPE-IV, LAMININ, C-ERBB-2 ONCOPROTEIN AND CATHEPSIN-D, Breast, 7(1), 1998, pp. 42-48
In a study of 83 breast cancer patients, tumour p53 protein expression
was studied by immunohistochemistry using the monoclonal antibody DO-
7. Its relationship with several prognostic variables such as: steroid
receptors, c-erbB-2 oncogene, Cathepsin D (CD), proliferative indices
Ki-67 and PCNA, as well as with expression of the basement membrane p
roteins collagen type IV and laminin was investigated. p53 protein exp
ression was detected in 51.8% of tumours (43 of 83). Expression was in
dependent of c-erbB-2 overexpression, proliferating index as measured
by Ki-67, CD expression and steroid receptor status. Also, p53 accumul
ation was not correlated with any other conventional clinicopathologic
al parameter considered in this study. A significant positive correlat
ion was found between p53 protein expression and collagen type IV expr
ession (P < 0.05), and PCNA-LI (P < 0.05). These data suggest that p53
protein could play an important role in the expansion of breast cance
r and in proliferative activity, as determined by PCNA-LI. The results
do not resolve whether detectable p53 protein expression represents a
random product in tumours with high collagen type IV expression or wh
ether it is an important feature of the malignant phenotype in the exp
ansion of breast cancer.